Concept Life Sciences appoints Philip Payne as Chief Commercial Officer


Philip Payne

Philip Payne

Concept Life Sciences, the integrated drug discovery, development and analytical services company, has announced the appointment of Philip Payne as Chief Commercial Officer, to support the group’s continued growth.

Philip completes Concept’s leadership team, following the appointment in August of John Handley as COO.

Philip will work with Concept’s executive team and board to drive the group’s commercial strategy, leading the business development function and helping to guide the next stage of the Company’s growth.

He will be responsible for managing the sales team, including identification of new service areas, geographies and markets, supporting the broadening of Concept’s reach into Europe and the US.

Philip has 27 years’ experience in managing the integration of business development in an international environment, and has gained cross-sector expertise through roles in pharma and biotech discovery as well as analytical and development services.

He joins Concept from Aptuit, where he held various roles, including Vice President of Sales, and was responsible for the global business development team and strategic accounts.

Prior to joining Aptuit he was Business Development Director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions and Pharmaceutical Business Development Director with Reading Scientific Services Ltd.

Michael Fort, Executive Chairman, Concept Life Sciences, said: “Philip’s experience in managing multidisciplinary, international teams across a range of industries will be a great asset as Concept’s rapid rate of expansion continues. Following on from John’s appointment as COO, Concept now has an extremely strong leadership team.”

Sign up for your free email newsletter